Mustang Bio, Inc. (MBIO) Stock Forecast
MBIO analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $10.00 average of analyst targets
- Upside to target
- +2,559.6% from the latest close
- Next earnings
- November 6, 2026
- 52-week range
- $0.37 – $1.57
MBIO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MBIO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | −$17.50 | — | — |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MBIO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | — | — |
MBIO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MBIO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MBIO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MBIO beat in 4 of 6.
What analysts expect from MBIO
The average price target is $10.00, 2,559.6% above the latest close of $0.38. For 2026 the average estimate is $0.00 per share. Mustang Bio beat the EPS estimate in 4 of the last 6 quarters.
Related: MBIO income statement, MBIO key metrics, MBIO chart. See the MBIO stock overview for the latest quote and news.
MBIO forecast FAQ
What is Mustang Bio's price target?
The average analyst price target for Mustang Bio is $10.00, 2,559.6% above the latest close of $0.38.
When does Mustang Bio report earnings?
Mustang Bio is expected to report results for the quarter ending September 30, 2026 on November 6, 2026.
Does Mustang Bio usually beat earnings estimates?
Mustang Bio reported EPS at or above the analyst estimate in 4 of the last 6 quarters.